Ecolab Inc.
ECL
NYSE·Basic Materials·Chemicals - Specialty·Mkt cap $78.6B
$279.28
▲ +0.11%
P/E
37.44
Mkt Cap
$78.6B
52-Wk Range
$243.15–$309.27
52-Week Range
$243.15 - $309.27
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 1.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Comprehensive industry-specific solutions
- Global distribution network
- Strong brand reputation
- Technical expertise and innovation
Bear Case
2 risks
- Average volatility.
- Significant premium - growth priced in
Growth
Stable outlook
Increasing demand for hygiene and sanitation
Value
Significant premium - growth priced in
Momentum
Strong
+8.5% over 3m
Quality
Strong
Strong fundamentals
Dividend
Modest
1.02% yield
Smart-money signal
Who's buying ECL right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 27, 2026
JUL 28, 2026
Reported EPS of $2.09 vs $2.08 consensus (+0.5% surprise). Revenue of $4.4B vs $4.4B expected (+0.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+0.5%
Revenue trend · last 8Q
—
+2%
-2%
+1%
+4%
+5%
+10%
+10%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$4.0B
$4.0B
$3.7B
$4.0B
$4.2B
$4.2B
$4.1B
$4.4B
Margins · last 8Q
Gross
-40.1%
Operating
17.2%
Profit
12.1%
Wall Street consensus
11 analysts · 91% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
91%
Hold
9%
Sell
0%
Median Price Target
—
Latest: UBS · Jul 29, 2026
vs Industry
How ECL stacks vs Chemicals - Specialty
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related